Status:
TERMINATED
Idiopathic Anemia of Aging (IAA)
Lead Sponsor:
National Institute on Aging (NIA)
Conditions:
Anemia
Aging
Eligibility:
All Genders
70+ years
Phase:
PHASE2
Brief Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
Detailed Description
As individuals become older, the frequency of anemia increases. While the cause of anemia in many cases can be determined and corrected, in a number of individuals there is no correctable cause found ...
Eligibility Criteria
Inclusion
- 70 years of age or older
- Diagnosed with anemia
- Hemoglobin level less than or equal to 11
- Able to perform most activities of daily living without restriction
Exclusion
- History of serious heart, liver or kidney disease
- Cancer treated within the last year except for skin cancer (excluding melanoma)
- Problems with your immune system
- Received Epoetin Alfa within the last year
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00104169
Start Date
August 1 2004
End Date
May 1 2007
Last Update
August 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harbor Hospital
Baltimore, Maryland, United States, 21225